Document Detail

The association between anti-Müllerian hormone and IVF pregnancy outcomes is influenced by age.
MedLine Citation:
PMID:  21044868     Owner:  NLM     Status:  In-Process    
The conflicting results from studies on the predictive capabilities of serum anti-Müllerian hormone (AMH) for IVF pregnancy outcomes may be attributed to small sample sizes and disparities in the age of the study populations. The relationship between AMH and IVF pregnancy outcomes was clarified with retrospective cross-tabulation analyses (n=1558) stratified by age to control for its confounding effects. Serum AMH concentrations were divided into tertiles (≤ 0.29, 0.30-1.20, ≥ 1.21 ng/ml) and ages into four groups (<34, 34-37, 38-41, ≥ 42 years). For women <34, having serum AMH in the lowest tertile did not reduce the chance of IVF pregnancy/live birth compared with those with higher AMH concentrations. For women 34-41, a significant positive relationship existed between serum AMH and pregnancy rates. For women ≥ 42, serum AMH concentrations ≤ 0.29 ng/ml were associated with a 3% chance of pregnancy, and women with AMH ≥ 1.21 ng/ml had the same pregnancy rate as women with concentrations 0.30-1.20 ng/ml. In conclusion, AMH has limited predictive value for IVF outcomes in the two extremes of female reproductive age; however, for women between 34 and 41, higher serum AMH concentrations are associated with significantly greater chances of pregnancy (P<0.01).
Jeff G Wang; Nataki C Douglas; Gary S Nakhuda; Janet M Choi; Susanna J Park; Melvin H Thornton; Michael M Guarnaccia; Mark V Sauer
Related Documents :
3926008 - Lithium in pregnancy--avoidance of toxicity. a case report.
14691998 - Adam12: a novel first-trimester maternal serum marker for down syndrome.
18698218 - Endogenous soluble receptor for advanced glycation endproducts is increased in preeclam...
1168998 - Serum amylase changes during pregnancy.
8714868 - A pilot neurodevelopmental study of seychellois children following in utero exposure to...
8750298 - Paralytic ileus in a fetus-neonate after maternal intake of benzodiazepine.
Publication Detail:
Type:  Journal Article     Date:  2010-11-01
Journal Detail:
Title:  Reproductive biomedicine online     Volume:  21     ISSN:  1472-6491     ISO Abbreviation:  Reprod. Biomed. Online     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101122473     Medline TA:  Reprod Biomed Online     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  757-61     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  New Turkish legislation on assisted reproductive techniques and centres: a step in the right directi...
Next Document:  Gold standard. Reply: Editorial. J Pediatr Urol 2010;6:329.